The abstract is read at the publisher; the summary is JClub's.
Acral melanoma on palms, soles, and the nail apparatus shows low mutational burden but extensive structural genomic alterations, including CCND1 and TERT amplifications within clustered copy-number “hailstorms”/tyfonas.
- Why it matters: Management is largely extrapolated from sun-exposed cutaneous melanoma, while immunotherapy and targeted-therapy benefits remain unclear because AM trials enroll few patients and under-represent diverse populations.
- What they did: This review integrates existing AM research on structural genomics, mechanical stress, and distinct clonal evolution, emphasizing late, often subclonal MAPK mutations and highlighting research priorities.
- The result: It outlines how global collaboration and AM-specific discovery efforts could close knowledge gaps and improve patient outcomes despite current evidence limitations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.